Internal Medicine, Critical Care Medicine · Lake Charles, LA
NPI
1265872725
Since 2013
Specialty
Internal Medicine, Critical Care Medicine
Code 207RC0200X
Group practices
7
Medicare group memberships
Hospitals
4
Hospital affiliations
2770 3rd Ave Ste 350
Lake Charles, LA, 70601
Phone (337) 494-2750
Groups this clinician bills Medicare through
Medicare paid, 2024
$226K
3,005 services
Medicare patients, 2024
868
Average age 74
Drug cost, 2024
$2.8M
4,798 prescriptions
Company payments, 2025
$3,777
From 21 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Fidencio H Davalos was code 99214 (office e&m - established), 889 times for 509 patients. In total Fidencio H Davalos billed 3,005 services in 52 codes, and Medicare paid $226K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-03-16.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 889 | 509 | $82.14 | $73K |
| 99291 Critical Care E&M | Facility | 408 | 170 | $155.07 | $63K |
| 99233 Hospital E&M - Subsequent | Facility | 366 | 176 | $86.07 | $32K |
| 94729 Pulmonary Function Testing | Office | 192 | 192 | $6.04 | $1,160 |
| 94726 Pulmonary Function Testing | Office | 187 | 187 | $8.14 | $1,522 |
| 94010 Pulmonary Function Testing | Office | 115 | 115 | $5.43 | $624 |
| 99205 Office E&M - New | Office | 105 | 105 | $144.78 | $15K |
| 71046 X-ray - Chest | Office | 95 | 93 | $15.27 | $1,450 |
| 99215 Office E&M - Established | Office | 69 | 66 | $120.26 | $8,298 |
| 99223 Hospital E&M - Initial | Facility | 65 | 61 | $119.02 | $7,736 |
| 94375 Pulmonary Function Testing | Office | 52 | 52 | $10.21 | $531 |
| 31624 Bronchoscopy | Facility | 35 | 34 | $61.54 | $2,154 |
| 94060 Pulmonary Function Testing | Office | 29 | 29 | $7.04 | $204 |
| 94644 Treatment - Miscellaneous | Office | 29 | 27 | $38.25 | $1,109 |
| 99152 Anesthesia | Facility | 26 | 21 | $9.05 | $235 |
By year: 2022 $164K for 1,756 services; 2023 $241K for 2,992 services; 2024 $226K for 3,005 services.
Medicare prescription drug claims, 2024
In 2024, the drug Fidencio H Davalos prescribed most often to Medicare patients was Montelukast Sodium, with 579 prescriptions and refills. In total Fidencio H Davalos wrote 4,798 Medicare prescriptions that cost $2.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Montelukast Sodium Generic | 579 | 1,184 | 155 | $4,700 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 531 | 620 | 162 | $18K |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 422 | 557 | 96 | $350K |
| Furosemide Generic | 273 | 446 | 70 | $789 |
| Pantoprazole Sodium Generic | 244 | 390 | 61 | $1,814 |
| Theophylline Er Theophylline Anhydrous | 228 | 385 | 65 | $30K |
| Roflumilast Generic | 166 | 209 | 37 | $15K |
| Potassium Chloride Generic | 162 | 232 | 37 | $1,385 |
| Dupixent Pen Dupilumab | 124 | 124 | 15 | $470K |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 123 | 147 | 37 | $87K |
| Prednisone Generic | 113 | 131 | 72 | $261 |
| Fluticasone Propionate Generic | 105 | 176 | 42 | $1,189 |
| Ipratropium Bromide Generic | 99 | 132 | 31 | $2,208 |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 91 | 131 | 19 | $58K |
| Torsemide Generic | 84 | 168 | 25 | $1,027 |
Brand drugs: - claims; generic drugs: 2,921 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Fidencio H Davalos $3,777 ($3,777 in general payments such as food, travel and fees) from 21 companies. The largest payer was GlaxoSmithKline, LLC. with $577.
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. GSK | 38 | $577 |
| AstraZeneca Pharmaceuticals LP AZN | 20 | $513 |
| Genzyme Corporation SNY | 21 | $424 |
| Viatris Specialty LLC | 9 | $273 |
| Grifols USA, LLC | 12 | $258 |
| Insmed, Inc. INSM | 17 | $254 |
| Merck Sharp & Dohme LLC MRK | 13 | $245 |
| Regeneron Healthcare Solutions, Inc. REGN | 8 | $225 |
| Verona Pharma, Inc. VRNA | 10 | $223 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 8 | $208 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.